Mohler JL - Search Results

1

The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes.

Schroeder JC, Bensen JT, Su LJ, Mishel M, Ivanova A, Smith GJ, Godley PA, Fontham ET, Mohler JL. Schroeder JC, et al. Among authors: mohler jl. Prostate. 2006 Aug 1;66(11):1162-76. doi: 10.1002/pros.20449. Prostate. 2006. PMID: 16676364

2

Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.

Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR, Marshall ME. Mohler JL, et al. Prostate. 1992;20(2):123-31. doi: 10.1002/pros.2990200208. Prostate. 1992. PMID: 1549551 Clinical Trial.

3

Cancer cell motility-inhibitory protein in the Dunning adenocarcinoma model.

Mohler JL, Broskie EN, Ranparia DJ, Sharief Y, Coleman WB, Smith GJ. Mohler JL, et al. Cancer Res. 1992 Apr 15;52(8):2349-52. Cancer Res. 1992. PMID: 1559238

4

Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model.

Mohler JL, Bakewell WE, Sharief Y, Coleman WB, Chay CH, Silvers SM, Smith GJ. Mohler JL, et al. Clin Exp Metastasis. 1995 Nov;13(6):474-80. doi: 10.1007/BF00118186. Clin Exp Metastasis. 1995. PMID: 7586805

5

Genetic instability assessed by sister chromatid exchange analysis in the Dunning R-3327 rat prostatic adenocarcinoma model and its relationship to metastatic potential.

Sharief Y, Mohler JL. Sharief Y, et al. Among authors: mohler jl. Prostate. 1995 May;26(5):247-52. doi: 10.1002/pros.2990260504. Prostate. 1995. PMID: 7753709

6

Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.

Zhang XZ, Donovan MP, Williams BT, Mohler JL. Zhang XZ, et al. Among authors: mohler jl. Urology. 1996 Mar;47(3):402-4. doi: 10.1016/S0090-4295(99)80460-9. Urology. 1996. PMID: 8633409 Clinical Trial.

7

Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma.

Godley PA, Campbell MK, Miller C, Gallagher P, Martinson FE, Mohler JL, Sandler RS. Godley PA, et al. Among authors: mohler jl. Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):115-9. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8850272

8

Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma.

Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, Sandler RS. Godley PA, et al. Among authors: mohler jl. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):889-95. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8922296

9

Expectant management as an option for men with stage T1c prostate cancer: a preliminary study.

Mohler JL, Williams BT, Freeman JA. Mohler JL, et al. World J Urol. 1997;15(6):364-8. doi: 10.1007/BF01300184. World J Urol. 1997. PMID: 9436286

10

Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia.

Allen MV, Smith GJ, Juliano R, Maygarden SJ, Mohler JL. Allen MV, et al. Among authors: mohler jl. Hum Pathol. 1998 Apr;29(4):311-8. doi: 10.1016/s0046-8177(98)90109-5. Hum Pathol. 1998. PMID: 9563778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters